| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Carlo Maria Croce | Q640381 |
| P2093 | author name string | Rami I Aqeilan | |
| Nicola Zanesi | |||
| Yuri Pekarsky | |||
| P2860 | cites work | TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma | Q40812531 |
| P433 | issue | 5 | |
| P921 | main subject | leukemia | Q29496 |
| lymphocyte | Q715347 | ||
| P304 | page(s) | 1109-1118 | |
| P577 | publication date | 2007-04-01 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | Animal models for chronic lymphocytic leukemia | |
| P478 | volume | 100 |
| Q24618669 | 13q14 deletions in CLL involve cooperating tumor suppressors |
| Q44640313 | Accumulation of B1-like B cells in transgenic mice over-expressing catalytically inactive RAG1 in the periphery |
| Q39807151 | Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition |
| Q37318047 | B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice |
| Q38161351 | Cancer stem cells of differentiated B-cell malignancies: models and consequences |
| Q36981744 | Chemical exposures and risk of chronic lymphocytic leukaemia |
| Q23917829 | Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis |
| Q37091230 | Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. |
| Q37097867 | HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment |
| Q48334926 | MicroRNAs in cancer: personalizing diagnosis and therapy |
| Q24618980 | MicroRNAs in mouse models of lymphoid malignancies |
| Q49196241 | Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia. |
| Q37791680 | Molecular basis of CLL |
| Q39214500 | Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia |
| Q24649526 | Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model |
| Q37690750 | NF-kappaB as a therapeutic target in chronic lymphocytic leukemia |
| Q37495234 | ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice |
| Q38223793 | Role of miR-15/16 in CLL. |
| Q34557974 | Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL |
| Q37018730 | Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. |
| Q31040364 | Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. |
| Q33492280 | The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB. |
| Q34710882 | The genomic landscape of chronic lymphocytic leukemia: clinical implications |
| Q37760875 | Therapeutic applications of bioactive sphingolipids in hematological malignancies |
| Q38135352 | miR deregulation in CLL. |
Search more.